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The CIAO Study (“Complicated Intra-Abdominal infection Observational” Study) is a multicenter investigation
performed in 68 medical institutions throughout Europe over the course of a 6-month observational period
(January-June 2012).
Patients with either community-acquired or healthcare-associated complicated intra-abdominal infections (IAIs)
were included in the study.
2,152 patients with a mean age of 53.8 years (range: 4–98 years) were enrolled in the study. 46.3% of the patients
were women and 53.7% were men. Intraperitoneal specimens were collected from 62.2% of the enrolled patients,
and from these samples, a variety of microorganisms were collectively identified.
The overall mortality rate was 7.5% (163/2.152).
According to multivariate analysis of the compiled data, several criteria were found to be independent variables
predictive of patient mortality, including patient age, the presence of an intestinal non-appendicular source of infection
(colonic non-diverticular perforation, complicated diverticulitis, small bowel perforation), a delayed initial intervention
(a delay exceeding 24 hours), sepsis and septic shock in the immediate post-operative period, and ICU admission.
Given the sweeping geographical distribution of the participating medical centers, the CIAO Study gives an accurate
description of the epidemiological, clinical, microbiological, and treatment profiles of complicated intra-abdominal
infections (IAIs) throughout Europe.* Correspondence: m.sartelli@virgilio.it
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Intra-abdominal infections (IAIs) include a wide spectrum
of pathological conditions, ranging from uncomplicated
appendicitis to fecal peritonitis.
In the event of complicated IAI [1], the infection pro-
ceeds beyond a singularly affected organ and causes
either localized peritonitis (intra-abdominal abscesses) or
diffuse peritonitis. Effectively treating patients with com-
plicated intra-abdominal infections involves both source
control and antimicrobial therapy [2,3].
Study design
The aim of the CIAO Study was to describe the epi-
demiological, clinical, microbiological, and surgical
treatment profiles of community-acquired and healthcare-
associated complicated intra-abdominal infections (IAIs)
based on data collected over a 6-month period (January-
June 2012) from 68 medical institutions throughout
Europe (see Figure 1).
Patients with either community-acquired or healthcare-
associated complicated intra-abdominal infections (IAIs)
were included in the study.
The center coordinator of each participating medical
institution collected and compiled clinical data in an
online case report database.
The collected data included the following: (i) patient
and disease characteristics, i.e. patient demographic data,
type of infection (nosocomial or community-acquired),
severity criteria, and previous antibiotic therapy admi-
nistered in the 7 days preceding surgery; (ii) origin of
infection, surgical procedures performed, and antibiotic
therapies administered; and (iii) microbiological data, i.e.Figure 1 Geographic distribution of the CIAO Study.identification of bacteria and microorganismal pathogens
within the peritoneal fluid, the identification of yeasts
(if present), and the antibiotic susceptibilities of bacterial
isolates.
This observational study did not attempt to change or
modify the laboratory or clinical practices of the partici-
pating physicians or their respective institutions, and it
did not require informed consent or formal approval by
an Ethics Committee.
A Scientific Committee was established to impartially
assess the objectives, methodology, and overall scientific
quality of the project.
The study was monitored by the coordination center,
which processed and verified missing or unclear data
submitted to the central database.
Statistical analysis was performed using STATAW stat-
istical software.Results
Patients
2,152 patients with a mean age of 53.8 years (range 4–98)
were enrolled in the CIAO Study. 996 patients (46.3%)
were women and 1,156 (53.7%) were men. Among these
patients, 1,701 (79%) were affected by community-
acquired IAIs while the remaining 451 (21%) suffered
from heathcare-associated infections. Intraperitoneal spe-
cimens were collected from 1,338 (62.2%) of the enrolled
patients.
787 patients (36.5%) were affected by generalized
peritonitis while 1,365 (63.5%) suffered from localized
peritonitis or abscesses.
Table 2 Radiological Procedures
Radiological procedures Patients
n° (%)
Abdomen X ray 198 (9.2%)
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(severe sepsis/septic shock).
Tables 1, 2 overviews the clinical findings and radio-
logical assessments recorded upon patient admission.
Abdomen X ray, CT 164 (7.6%)
Abdomen X ray, ultrasound 401(18.6%)
Abdomen X ray, ultrasound, CT 205 (9.5%)
Abdomen X ray, ultrasound, MRI 3 (0.1%)
CT 527 (24.5%)
Ultrasound 345 (16.0%)
Ultrasound, CT 160 (8.3%)
Ultrasound, CT, MRI 5 (0.2%)
Ultrasound, MRI 6 (0.3%)
Not reported 131 (6%)Source control
The various sources of infection are outlined in Table 3.
The most frequent source of infection was acute appen-
dicitis; 798 cases (37%) involved appendicitis.
The open appendectomy was the most common means
of addressing complicated appendicitis. 443 patients
(55.1%) admitted for complicated appendicitis underwent
open appendectomies: 343 patients (77.4%) for localized
infection or abscesses and 100 patients (29.1%) for gener-
alized peritonitis. A laparoscopic appendectomy was per-
formed for 318 patients (39.8%) with complicated acute
appendicitis; of these patients, 217 underwent the proced-
ure for localized peritonitis/abscesses and 101 underwent
the procedure for generalized peritonitis. Open bowel re-
section was performed for 7 patients affected by compli-
cated appendicitis. In the other 30 cases of complicated
appendicitis (4.3%), conservative treatment (percutaneous
drainage, surgical drainage, and non-operative treatment)
was performed. 1.6% of patients underwent percutaneous
drainage and interval appendectomies to address appen-
dicular abscesses.
Among the patients with complicated cholecystitis
(289), the open cholecystectomy was the most frequentlyTable 1 Clinical Findings
Clinical findings Patients
n° (%)
Abdominal pain 271 (12.6)
Abdominal pain, abdominal rigidity 192 (8.9%)
Abdominal pain, abdominal rigidità,
T>38°C or <36°C, WBC >12,000 or < 4,000
366 (17%)
Abdominal pain, abdominal rigidity,
T>38°C or <36°C,
70 (3.2)
Abdominal pain, abdominal rigidity,
WBC >12,000 or < 4,000
445 (20.7%)
Abdominal pain, T>38°C or <36°C, 71 (3.3%)
Abdominal pain, T>38°C or <36°C,
WBC >12,000 or < 4,000
235 (10.9%)
Abdominal pain, WBC >12,000 or < 4,000 325 (15.1)
T>38°C or <36°C 15 (0.7 %)
T>38°C or <36°C, WBC >12,000 or < 4,000 45 (2.0%)
Abdominal rigidity, WBC >12,000 or < 4,000 15 (0.7%)
Abdominal rigidity 15 (0.7%)
Abdominal rigidity, T>38°C or <36°C 22 (1%)
WBC >12,000 or < 4,000 32 (1.5%)
Not reported 33 (1.5%)performed procedure. 48.4% and 40.8% of cholecystitis
patients underwent open and laparoscopic cholecystecto-
mies, respectively. The remaining patients were treated
with conservative methods (percutaneous drainage, non-
operative treatment).
Among the patients with complicated diverticulitis
(166) the Hartmann resection was the most frequently
performed procedure. 73 patients (43.2%) underwent a
Hartmann resection, and of these resections, the vast
majority were open procedures (94.5% open compared to
5.5% laparoscopic). 54 of these patients (74%) underwent
a Hartmann resection for generalized peritonitis, while
the remaining 19 (26%) underwent the same procedure
for localized peritonitis or abscesses. Colo-rectal resec-
tion was performed in 41 cases (24.7%). Laparoscopic
resection was performed for only 3 patients (2 patients
with and 1 patient without protective stoma) while open
resection was performed for 38 patients (27 with and
11 without protective stoma).
The remaining patients received conservative treat-
ment (percutaneous drainage, non-operative treatment,Table 3 Source of Infection
Source of infection Patients
N 2152° (100%)
Appendicitis 798 (37%)
Cholecystitis 289 (13.4%)
Post-operative 342 (15.,9%)
Colonic non diverticular perforation 158 (7.3%)
Gastroduodenal perforations 156 (7.3%)
Diverticulitis 166 (7.7%)
Small bowel perforation 103 (4.8%)
Others 110 (5.1%)
PID 18 (0.8%)
Post traumatic perforation 12 (0.6%)
Table 4 Aerobic bacteria identified in peritoneal fluid
Total 1,525 (100%)
Aerobic Gram-negative bacteria 1,041 (69.2%)
Escherichia coli 632 (41.4%)
(Escherichia coli resistant to third
generation cephalosporins)
64 (4.2%)
Klebsiella pneuumoniae 109 (7.1%)
(Klebsiella pneumoniae resistant to third
generation cephalosporins)
37 (2.4%)
Enterobacter 63 (4.1%)
Proteus 33 (2.1 %)
Pseudomonas 80 (5.2%)
Others 124 (8.1%)
Aerobic Gram-positive bacteria 484 (31.7%)
Enterococcus faecalis 169 (11%)
Enterococcus faecium 72 (4.7%)
Staphylococcus Aureus 56 (3.7%)
Streptococcus spp. 100 (6,6%)
Others 87 (5.7%)
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laparoscopic drainage.
For patients with gastro-duodenal perforations (156
cases), the most common surgical procedure was
gastro-duodenal suture. 107 patients underwent open
gastro-duodenal suture (68.6%) and 18 patients under-
went laparoscopic gastro-duodenal suture (11.5%). 16
patients (10.3%) underwent gastro-duodenal resection
and 16 patients (10.3%) received conservative treat-
ment (non-operative treatment, surgical drainage). The
remaining patients underwent alternative procedures.
Of the 100 patients with small bowel perforations, 83
underwent open small bowel resection (83%) and 3 (3%)
underwent laparoscopic small bowel resection. The
remaining 14 patients (14%) were treated non-surgically.
Among the 158 patients with colonic non-diverticular
perforation, 52 (32.9%) underwent open Hartmann resec-
tion, 55 (34.8%) underwent open resection with anasto-
mosis and without stoma protection, and 23 underwent
open resection with stoma protection (14.6%).
369 cases (17.1%) were attributable to post-operative
infections. Anastomotic leaks were the most prevalent
cause of post-operative infection. Of all post-operative
infections, 40.2% resulted from colo-rectal leaks, 32.1%
from upper gastro-intestinal leaks, 14.5% from biliary
leaks, 11.2% from pancreatic leaks, and 1.9% from urinary
leaks.
Source control was successfully implemented for 1,985
patients (92%) and proved ineffective for 167 patients (8%).Microbiology
Intraperitoneal specimens were collected from 1,339
patients (62.2%).
These specimens were obtained from 977 of the 1,701
patients presenting with community-acquired intra-
abdominal infections (57.4%).
Intraperitoneal specimens were collected from 362
(80.3%) of the remaining 451 patients with nosocomial
intra-abdominal infections.
The major pathogens involved in intra-abdominal
infections were found to be Enterobacteriaceae.
The aerobic bacteria identified in samples of peritoneal
fluid are reported in Table 4.
In community-acquired IAIs, Extended-Spectrum
Beta-Lactamase (ESBL)-producing Escherichia coli iso-
lates comprised 10.1% (64/632) of all Escherichia coli
isolates, while ESBL-positive Klebsiella pneumoniae
isolates represented 33.9% (37/109) of all Klebsiella
pneumoniae isolates.
ESBL-positive Enterobacteriaceae were more prevalent
in patients with nosocomial IAIs than they were in
patients with community-acquired IAIs. ESBL-positive
Escherichia coli isolates comprised 22.4% (34/152) of allidentified Escherichia coli isolates, while ESBL-positive
Klebsiella pneumoniae isolates made up 50% (26/52) of all
identified Klebsiella pneumoniae isolates.
There were 5 isolates of Klebsiella pneumoniae resistant
to Carbapenems. All Carbapenem-resistant Klebsiella
pneumoniae isolates were acquired in an intensive care
setting.
Among the identified aerobic gram-negative isolates,
there were 80 isolates of Pseudomonas aeruginosa, com-
prising 5.3% of all identified aerobic bacteria isolates
(4.3% in patients with community-acquired infections
versus 6.7% in patients with nosocomial infections).
The 3 Pseudomonas aeruginosa strains resistant to
Carbapenems were also obtained from nosocomial
infections.
Among the identified aerobic gram-positive bacteria,
Enterococci (E. faecalis and E. faecium) were the most
prevalent, representing 16% of all aerobic isolates, and
were identified in 241 cases. 22 glycopeptide-resistant
Enterococci were identified; 16 were glycopeptide-
resistant Enterococcus faecalis isolates and 6 were
glycopeptide-resistant Enterococcus faecium isolates.
Although Enterococci were also present in community-
acquired infections, they were far more prevalent in
nosocomial infections.
Identified bacterial isolates from peritoneal fluid samples
in both nosocomial and community-acquired IAIs are
listed in Table 5.
Tests for anaerobes were conducted for 680 patients.
197 anaerobes were observed. The most frequently
identified anaerobic pathogen was Bacteroides. 126
Bacteroides isolates were observed during the course of
Table 6 Anaerobic bacteria identified in peritoneal fluid
Anaerobes 197
Bacteroides 126 (64%)
(Bacteroides resistant to Metronidazole) 4 (2%)
Clostridium 16 (8.1%)
(Clostridium resistant to Metronidazole) 1 (0.5%)
Others 55 (27.9%)
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Metronidazole-resistant strains.
Identified anaerobic bacteria are reported in Table 6.
Additionally, 138 Candida isolates were collectively
identified (4.7%). 110 were Candida albicans and 28
were non-albicans Candida. 2 Candida albicans isolates
and 7 non-albicans Candida isolates were resistant to
Fluconazole (see Table 7).Outcome
The overall mortality rate was 7.6% (163/2,152).
521 patients (24.2%) were admitted to the intensive
care unit in the early recovery phase immediately follow-
ing surgery.
255 post-operative patients (11.8%) ultimately required
additional surgeries; 66.7% of follow-up laparotomies
were unplanned “on-demand” procedures and 20% were
anticipated surgeries. Overall, 11.3% of these patients
underwent open abdominal procedures.
According to univariate statistical analysis of the data
(Table 8), severe sepsis (OR=14.6; 95%CI=8.7-24.4;
p<0.0001) and septic shock (OR=27.6; 95%CI=15.9-47.8;
p<0.0001) upon hospital admission were both predictive
of patient mortality.
For healthcare associated infections, the setting of
acquisition was also a variable found to be predictive
of patient mortality (chronic care setting: OR=5.2; 95%
CI=1.7-8.4; p<0.0001, non-operative hospital setting:
OR=3.8; 95%CI=2.4-10.9; p<0.0001, and post-operative
hospital setting: OR=2.5; 95%CI=1.7-3.7; p<0.0001).
Among the various sources of infection, colonic non-
diverticular perforation (OR=117.4; 95%CI=27.9-493.9,
p<0.0001), complicated diverticulitis (OR=45.4; 95%
CI=10.4-198.6; p<0.0001), and small bowel perforation
(OR=125.7; 95%CI=29.1-542; p<0.0001) were signifi-
cantly correlated with patient mortality.
Mortality rates did not vary to a statistically significant
degree between patients who received adequate sourceTable 5 Aerobic bacteria in community-acquired and healthca
Community-acquired IAIs Isolates
n°
Aerobic bacteria 988 (100%)
Escherichia coli 480 (48.6%)
(Escherichia coli resistant to third
generation cephalosporins)
30 (3%)
Klebsiella pneumoniae 52 (5.2%)
(Klebsiella pneumoniae resistant to third
generation cephalosporins)
11 (1,7%)
Pseudomonas 42 (4.2%)
Enterococcus faecalis 78 (7.9%)
Enterococcus faecium 39 (3.9%)control and those who did not. However, a delayed initial
intervention (a delay exceeding 24 hours) was associated
with an increased mortality rate (OR=2.6; 95%CI=1.8-3.5;
p<0.0001).
The nature of the immediate post-operative clinical
period was a significant predictor of mortality (severe sep-
sis: OR=33.8; 95%CI=19.5-58.4; p<0.0001, septic shock:
OR=59.2; 95%CI=34.4-102.1; p<0.0001). Patients requiring
ICU admission (OR=18.6; 95%CI=12-28.7; p<0.0001) were
also associated with increased mortality rates.
WBC counts greater than 12,000 or less than 4,000
(OR=2.8; 95%CI=1.8-4.4; p<0.0001), and core body tem-
peratures greater than 38°C or less than 36°C (OR=3.3;
95%CI=2.2-5; p<0.0001) by the third post-operative day
were significant predictors of patient mortality.
According to stepwise multivariate analysis (PR=0.005
and PE=0.001) (Table 9), several criteria were found to
be independent variables predictive of mortality, in-
cluding patient age (OR=3.3; 95%CI=2.2-5; p<0.0001),
the presence of an intestinal non-appendicular source of
infection (colonic non-diverticular perforation: OR=4.7;
95%CI=2.5-8; p<0.0001, complicated diverticulitis:
OR=2.3; 95%CI=1.5-3.7; p<0.0001, small bowel perfor-
ation: OR=21.4; 95%CI=8-57.4; p<0.0001), a delayed ini-
tial intervention (a delay exceeding 24 hours) (OR=2.4;
95%CI=1.5-3.7; p<0.0001), severe sepsis (OR=6.6; 95%
CI=3.8-11; P<0.0001) and septic shock (OR=7.2; 95%
CI=4.12.5; p<0.0001) in the immediate post-operative
period, and ICU admission (OR=3.8; 95%CI=2.2-6.4;
p<0.0001).re-associated (nosocomial) IAIs
Healthcare-associated (nosocomial) IAIs Isolates
n°
Aerobic bacteria 567 (100%)
Escherichia coli 152 (26.8%)
(Escherichia coli resistant to third
generation cephalosporins)
34 (6%)
Klebsiella pneumoniae 57 (10%)
(Klebsiella pneumoniae resistant to third
generation cephalosporins)
22 (6.7%)
Pseudomonas 38 (6.7%)
Enterococcus faecalis 91 (16%)
Enterococcus faecium 43 (7.6%)
Table 7 Candida isolates identified in peritoneal fluid
Candida 138
Candida albicans 110 (79.7%)
(Candida albicans resistant to Fluconazole) 4 (2.9%)
Non-albicans Candida 28 (20.3%)
(non-albicans Candida resistant to Fluconazole) 5 (3.6%)
Table 9 Multivariate analysis: risk factors for occurrence
of death during hospitalization
Risk factors Odds ratio 95%CI p
Age 3.3 2.2-5 <0.0001
Severe sepsis in the immediate
post-operative course
27.6 15.9-47.8 <0.0001
Septic shock in the immediate
post-operative course
14.6 8.7-24.4 <0.0001
Colonic non diverticular
perforation
4.7 2.5-8 <0.0001
Diverticulitis 2.3 1.5-3.7 <0.0001
Small bowel perforation 21.4 8-57.4 <0.0001
Delayed initial intervention 2.4 1.5-3.7 0.0001
Stepwise multivariate analysis, PR=0.005 E PE=0.001 (Hosmer-Lemeshow chi2
(8)=1.68, area under ROC curve=0.9465).
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Source control
Complicated intra-abdominal infections are an import-
ant source of patient morbidity and are frequently asso-
ciated with poor clinical prognoses, particularly for
patients in high-risk categories.
The CIAO Study has confirmed that acute appendicitis
is the most common intra-abdominal condition requiring
emergency surgery in Europe. Both open and laparo-
scopic appendectomies are viable treatment options for
complicated appendicitis [4]. The laparoscopic appendec-
tomy is a safe and effective means of surgical treatment
for addressing complicated intra-abdominal infections,
but open surgery still retains several clinical advantages,
including a reduced probability of post-operative intra-
abdominal abscesses [5]. CIAO Study data indicate that
the open approach was used in 55.1% of complicated ap-
pendicitis cases while the laparoscopic approach was per-
formed in 39.8% of these cases.
For patients with periappendiceal abscesses, the proper
course of surgical treatment remains a point of contentionTable 8 Univariate analysis: risk factors for occurrence of
death during hospitalization
Risk factors Odds ratio 95%CI p
Clinical condition upon hospital admission
Severe sepsis 27.6 15.9-47.8 <0.0001
Septic shock 14.6 8.7-24.4 <0.0001
Healthcare associated infection
Chronic care setting acquired 5.2 1.7-8.4 <0.0001
Non post-operative hospital acquired 3.8 2.4-10.9 <0.0001
Post-operative 2.5 1.7-3.7 <0.0001
Source of infection
Colonic non diverticular perforation 117.4 27.9-493.9 <0.0001
Diverticulitis 45.4 10.4-198.6 <0.0001
Small bowel perforation 125.7 29.1-542 <0.0001
Delayed initial intervention 2.6 1.8-3.5 <0.0001
Immediate post-operative clinical course
Severe sepsis 33.8 19.5-58.4 <0.0001
Septic shock 59.2 34.4-102.1 <0.0001
ICU admission 18.6 12-28.7 <0.0001
WBC>12000 or <4000
(3nd post-operative day)
2.8 1.8-4.4 <0.0001
T>38°C or <36°C
(3nd post-operative day)
3.3 2.2-5 <0.0001in the medical community. However, this contention
notwithstanding, the most commonly employed treat-
ment appears to be drainage with subsequent append-
ectomy [6].
Although guidelines for the management of intra-
abdominal infections commonly assert that patients with
periappendiceal abscesses should be treated with percu-
taneous image-guided drainage, few patients underwent
this procedure.
The laparoscopic versus open cholecystectomy debate
has been extensively investigated in recent years. In the
CIAO Study, the open cholecystectomy was the most
common means of treating cholecystitis; 48.4% of
patients with complicated cholecystitis underwent this
procedure. By contrast, 118 patients (40.8%) underwent
the laparoscopic procedure.
The optimal surgical management of colonic diverticu-
lar disease complicated by peritonitis remains a contro-
versial issue in the medical community.
Hartmann’s resection has historically been considered
the procedure of choice for patients with generalized
peritonitis and continues to be a safe and reliable tech-
nique for performing an emergency colectomy in the
event of perforated diverticulitis, particularly in elderly
patients with multiple co-morbidities [7–10].
More recently, however, reports have suggested that
primary resection and anastomosis may be the optimum
approach to addressing diverticulitis, even in the pres-
ence of diffuse peritonitis [11].
According to CIAO Study data, the Hartmann resec-
tion was the most frequently performed procedure to
address complicated diverticulitis in Europe. 43.2% of
patients underwent a Hartmann resection, and of these
resections, the vast majority were open procedures (94.5%
open compared to 5.5% laparoscopic). 54 of these patients
(74%) underwent a Hartmann resection for generalized
peritonitis, while the remaining 19 (26%) underwent the
same procedure for localized peritonitis or abscesses.
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Microbiology
The significance of microbiological analysis of infected
peritoneal fluid in community-acquired intra-abdominal
infections has been debated in recent years.
Cultures from the site of infection should always be
obtained for patients with nosocomial infections as well
as for patients with community-acquired infections who
are known to be at risk for drug-resistant strains. In
these patients, causative pathogens and resistance pat-
terns are unpredictable and always require cultures from
the site of infection [4].
Bacterial cultures and analyses may be often clinically
superfluous, particularly when the etiological agents are
readily predictable [12]. However, some authors maintain
that in-depth bacterial diagnosis has practical significance,
even in low-risk patients with community-acquired IAIs.
They argue that this analysis plays an important role in
documenting epidemiological shifts in antimicrobial re-
sistance patterns associated with community-acquired
IAIs and in guiding individualized follow-up therapy. For
high-risk patients with community-acquired IAIs or in the
event of nosocomial IAIs, clinicians should always obtain
cultures from the site of infection.
According to CIAO Study data, intraperitoneal speci-
mens were collected from 62.2% of patients; these sam-
ples were obtained from 57.4% of patients with
community-acquired IAIs and from 80.3% of patients
with nosocomial IAIs.
In many clinical laboratories, species identification and
susceptibility testing of anaerobic isolates are not rou-
tinely performed [13].
Of the total patients tested for aerobic microorgan-
isms, 42.9% underwent tests for anaerobes.
The major pathogens involved in community-acquired
intra-abdominal infections are Enterobacteriaceae,
Streptococcus species, and certain anaerobes (particularly
B. fragilis). Compared to community-acquired infections,
nosocomial infections typically involved a broader spec-
trum of microorganisms, encompassing ESBL-producing
Enterobacteriaceae, Enterococcus, Pseudomonas, and
Candida species in addition to the Enterobacteriaceae,
Streptococcus species, and anaerobes observed in
community-acquired IAIs.
Antimicrobial resistance has become a major challenge
complicating the treatment and management of intra-
abdominal infections.
The main resistance threat is posed by ESBL-
producing Enterobacteriaceae, which are becoming in-
creasingly common in community-acquired infections.
Many factors can increase the prevalence of ESBL ac-
tivity in community-acquired intra-abdominal infections,including excessive use of antibiotics, residence in a
long-term care facility, and recent hospitalization. Fur-
ther, male patients and patients over the age of 65 ap-
pear to be particularly susceptible to ESBL-producing
bacterial infections [14].
According to CIAO Study data, ESBL producers were
the most commonly identified drug-resistant micro-
organism involved in IAIs.
Recent years have seen an escalating trend of Klebsi-
ella pneumoniae Carbapenemase (KPC) production,
which continues to cause serious multidrug-resistant
infections around the world. The recent emergence of
Carbapenem-resistant Enterobacteriaceae is a major
threat to hospitalized patients.
In addition to hydrolyzing Carbapenems, KPC-
producing strains are also resistant to a variety of other
antibiotics, and consequently, these infections pose a con-
siderable challenge for clinicians in acute care situations.
KPC-producing bacteria are most common in nosoco-
mial infections, particularly in patients with previous
exposure to antibiotics [15].
5 identified isolates of Klebsiella pneumoniae proved
resistant to Carbapenems, and each was acquired in an
intensive care setting.
The rate of Pseudomonas aeruginosa among aerobic
isolates was 5.2%. There was no statistically signifi-
cant difference in Pseudomonas prevalence between
community-acquired and nosocomial IAIs.
Enterococci (E. faecalis and E. faecium) were identified
in 15.7% of all aerobic isolates.
Although Enterococci were also identified in
community-acquired infections, they were far more
prevalent in nosocomial infections.
In the CIAO Study, 138 Candida isolates were observed
among 1,890 total isolates (7.3%). Candida prevalence was
significantly higher in the nosocomial IAI group than it
was in the community-acquired IAI group.
Outcome
Of the 2,152 patients enrolled in the study, there were
163 deaths (7.6%).
According to univariate statistical analysis of the data,
critical clinical condition of the patient upon hospital
admission (defined by severe sepsis/septic shock) as
well as critical clinical condition in the immediate post-
operative period and ICU admission were all significant
risk factors predictive of patient mortality. WBCs
greater than 12,000 or less than 4,000 and core body
temperatures greater than 38°C or less than 36°C by the
third post-operative day were predictors of patient mor-
tality. Among the various sources of infection, colonic
non-diverticular perforations, complicated diverticulitis,
and small bowel perforations correlated strongly with
patient mortality.
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degree between patients who received adequate source
control and those who did not. However, a delayed ini-
tial intervention (a delay exceeding 24 hours) was asso-
ciated with an increased mortality rate.
According to stepwise multivariate analysis (PR=0.005
and PE=0.001), several criteria were found to be inde-
pendent variables predictive of patient mortality, including
patient age, the presence of an intestinal non-appendicular
source of infection (colonic non-diverticular perforation,
complicated diverticulitis, small bowel perforation), a
delayed initial intervention (a delay exceeding 24 hours),
sepsis and septic shock in the immediate post-operative
period, and ICU admission.Conclusion
Complicated intra-abdominal infections remain an im-
portant source of patient morbidity and are frequently
associated with poor clinical prognoses, particularly for
patients in high-risk categories.
Given the sweeping geographical distribution of the
participating medical centers, the CIAO Study gives an
accurate description of the epidemiological, clinical,
microbiological, and treatment profiles of complicated
intra-abdominal infections (IAIs) throughout Europe.
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